Inhibikase Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $14.5M
Liabilities Breakdown FY2023
Total Liabilities: $3.5M
Asset Breakdown
Total Assets: $14.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.2M | 63.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $73.4K | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.2M | 36.1% |
Liabilities Breakdown
Total Liabilities: $3.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $646.8K | 18.3% |
| Long-Term Debt | $381.8K | 10.8% |
| Other Liabilities | $2.5M | 70.9% |